Advanced Renal Technologies, Inc.

Click Here To EMAIL INQUIRY
Web: http://www.advrenaltech.com
E-Mail:
Address: 40 Lake Bellevue, Suite 100, Bellevue, Washington 98005, USA
Phone: +1-(425)-453-8777 | Fax: +1-(425)-451-9438 | Map/Directions >>

Profile: Advanced Renal Technologies, Inc. provides an advanced dialysis fluid (dialysate) formulation containing citric acid. Citrate dialysate is available in two forms, Citrasate® liquid A concentrate and DRYalysate® , a dry powdered version that can be mixed by the user to make A concentrate. The use of citric acid in the dialysate offers a safe and effective way to provide dialysis therapy. Citrate dialysis provides improved treatment for patients on routine long-term hemodialysis. Citrate dialysate is safe and effective in all dialysis patients. Citrasate® and DRYalysate® are available in all standard formulations. Citrasate® liquid A concentrate is available in individual-dose gallon jugs packaged four per case, and it is also available in 50- and 55-gallon barrels. Citric acid is a physiological acid that is rapidly metabolized. It has a long and safe history of use in medicine, most notably as an anticoagulant used in the collection & storage of blood for transfusion. Citric acid anticoagulates through the chemical binding of calcium. Citrate dialysate contains a small fraction of the citric acid concentration used to anticoagulate blood. It has mild anticoagulation properties that improve dialysis treatment.

The company was founded in 1992, has revenues of < USD 1 Million.

2 Products/Services (Click for related suppliers)

• Dialysis Fluids

• Liquid Hemodialysis Dialysate Concentrate Solution (FDA Code: KPO / 876.5820)

A hemodialysis system and accessories is a device that is used as an artificial kidney system for the treatment of patients with renal failure or toxemic conditions and that consists of an extracorporeal blood system, a conventional dialyzer, a dialysate delivery system, and accessories. Blood from a patient flows through the tubing of the extracorporeal blood system and accessories to the blood compartment of the dialyzer, then returns through further tubing of the extracorporeal blood system to the patient. The dialyzer has two compartments that are separated by a semipermeable membrane. While the blood is in the blood compartment, undesirable substances in the blood pass through the semipermeable membrane into the dialysate in the dialysate compartment. The dialysate delivery system controls and monitors the dialysate circulating through the dialysate compartment of the dialyzer.